Review article · 2015 · Open access
CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape
Viruses, 7(8), 4186–4203 · Published 27 July 2015 · DOI 10.3390/v7082816
In brief
“CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape” is a 2015 review article by Gero Hütter and 6 co-authors, published in Viruses. OpenAlex counts 106 citations as of 19 November 2026, which puts it in the top 7% of works published in 2015 by citations. It is open access under a CC BY licence: the full text is free to read at Viruses.
- Citations
- 106
- Most cited in
- 2018 (21)
- Field-weighted impact
- 1.59
- References
- 70
- Authors
- 7
Abstract
Allogeneic transplantation with CCR5-delta 32 (CCR5-d32) homozygous stem cells in an HIV infected individual in 2008, led to a sustained virus control and probably eradication of HIV. Since then there has been a high degree of interest to translate this approach to a wider population. There are two cellular ways to do this. The first one is to use a CCR5 negative cell source e.g., hematopoietic stem cells (HSC) to copy the initial finding. However, a recent case of a second allogeneic transplantation with CCR5-d32 homozygous stem cells suffered from viral escape of CXCR4 quasi-species. The second way is to knock down CCR5 expression by gene therapy. Currently, there are five promising techniques, three of which are presently being tested clinically. These techniques include zinc finger nucleases (ZFN), clustered regularly interspaced palindromic repeats/CRISPR-associated protein 9 nuclease (CRISPR/Cas9), transcription activator-like effectors nuclease (TALEN), short hairpin RNA (shRNA), and a ribozyme. While there are multiple gene therapy strategies being tested, in this review we reflect on our current knowledge of inhibition of CCR5 specifically and whether this approach allows for consequent viral escape.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Hütter, G., Bodor, J., Ledger, S., Boyd, M. P., Millington, M., Tsie, M. S., & Symonds, G. P. (2015). CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape. Viruses, 7(8), 4186–4203. https://doi.org/10.3390/v7082816
MLA 9
Hütter, Gero, et al. “CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.” Viruses, vol. 7, no. 8, 2015, pp. 4186–4203. https://doi.org/10.3390/v7082816.
Chicago
Hütter, Gero, Josef Bodor, Scott Ledger, Maureen P. Boyd, Michelle Millington, Marlene S. Tsie, and Geoff P. Symonds. 2015. “CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.” Viruses 7 (8): 4186–4203. https://doi.org/10.3390/v7082816.
Harvard
Hütter, G. et al. (2015) ‘CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape’, Viruses, 7(8), pp. 4186–4203. doi:10.3390/v7082816.
IEEE
G. Hütter et al., “CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape,” Viruses, vol. 7, no. 8, pp. 4186–4203, 2015, doi: 10.3390/v7082816.
BibTeX
@article{hutter2015targeted,
title = {{CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape}},
author = {Hütter, Gero and Bodor, Josef and Ledger, Scott and Boyd, Maureen P. and Millington, Michelle and Tsie, Marlene S. and Symonds, Geoff P.},
journal = {Viruses},
year = {2015},
volume = {7},
number = {8},
pages = {4186--4203},
doi = {10.3390/v7082816},
url = {https://doi.org/10.3390/v7082816}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 9 | |
| 2018 | 21 | |
| 2019 | 13 | |
| 2020 | 15 | |
| 2021 | 11 | |
| 2022 | 8 | |
| 2023 | 4 | |
| 2024 | 5 | |
| 2025 | 2 | |
| 2026 | 2 |
Its field-weighted citation impact is 1.59: it has been cited 1.59 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- CCR5
- HIV
- CCR5Δ32
- allogeneic stem cell transplantation
- viral immune evasion
- CXCR4
- hematopoietic stem cells
- gene therapy
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Hütter, G., Bodor, J., Ledger, S., Boyd, M. P., Millington, M., Tsie, M. S., & Symonds, G. P. (2015). CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape. Viruses, 7(8), 4186–4203. https://doi.org/10.3390/v7082816
How many times has this paper been cited?
106 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Viruses: sign in and open the PDF from this page.
Who wrote this paper?
Gero Hütter, Josef Bodor, Scott Ledger, Maureen P. Boyd, Michelle Millington, Marlene S. Tsie, Geoff P. Symonds.
What is the DOI of this paper?
10.3390/v7082816, permanently at https://doi.org/10.3390/v7082816. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.